ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013

Bioassay Backlog Catch Up Planned By Mid-February

August 26, 1977

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

FOLFOX4 Improved PFS In Colorectal Cancer

April 25, 2008

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

First Compound From New In Vitro Screening to Enter Clinical Trials

December 5, 1986